4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001415889-25-023791
CHIEF EXECUTIVE OFFICER acquired 90,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Seehra Jasbir CHIEF EXECUTIVE OFFICER | 2025-09-03 | Grant or award | +90,500 | 392,723 | D |
Loading xslF345X05/form4-09052025_040903.xml…